Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Hans-Peter Hauser has worked on the following 12 EPO patent applications which have been published in the last five years:

EP12777895

USE OF SULFATED GLYCOSAMINOGLYCANS FOR IMPROVING THE BIOAVAILABILITY OF FACTOR VIII

IPC classification:
A61K 38/36, A61K 38/37, A61K 47/36, A61K 47/42, A61P 7/04
Applicant:
CSL Behring GmbH
Agent:
Hans-Peter Hauser, CSL Behring GmbH
Status:
PATENT GRANTED
EP12772969

COMBINED USE OF A SULFATED GLYCOSAMINOGLYCAN AND A HYALURONIDASE FOR IMPROVING THE BIOAVAILABILITY OF FACTOR VIII

IPC classification:
A61K 38/36, A61K 38/37, A61K 47/36, A61K 47/42, A61P 7/04
Applicant:
CSL Behring GmbH
Agent:
Hans-Peter Hauser, CSL Behring GmbH
Status:
PATENT GRANTED
EP12772987

METHOD FOR IMPROVING THE STABILITY OF PURIFIED FACTOR VIII AFTER RECONSTITUTION

IPC classification:
A61K 38/37, C07K 14/755
Applicant:
CSL Ltd.
Agent:
Hans-Peter Hauser, CSL Behring GmbH
Status:
EXAMINATION IN PROGRESS
EP12859136

DOSAGE REGIME FOR APOLIPOPROTEIN FORMULATIONS

IPC classification:
A61K 35/14, A61K 38/17, A61P 9/00
Applicant:
CSL Ltd.
Agent:
Hans-Peter Hauser, CSL Behring GmbH
Status:
GRANT OF PATENT INTENDED
EP14192277

Factor VIII, von Willebrand factor or complexes thereof with prolonged in vivo half-life

IPC classification:
A61K 38/37, C07K 14/755, C12N 5/10, C12N 15/12, G01N 33/86
Applicant:
CSL Behring GmbH
Agent:
Hans-Peter Hauser, CSL Behring GmbH
Status:
The patent has been granted
EP15193455

METHOD FOR PURIFICATION OF ALPHA-1-ANTITRYPSIN

IPC classification:
C07K 14/81
Applicant:
CSL Behring LLC
Agent:
Hans-Peter Hauser, CSL Behring GmbH
Status:
EXAMINATION REQUESTED
EP11799979

A RECONSTITUTED HIGH DENSITY LIPOPROTEIN FORMULATION AND PRODUCTION METHOD THEREOF

IPC classification:
A61K 31/56, A61K 31/685, A61K 38/17, A61P 3/06, A61P 9/10
Applicant:
CSL Ltd.
Agent:
Hans-Peter Hauser, CSL Behring GmbH
Status:
PATENT GRANTED
EP14859399

NEW METHOD TO CONCENTRATE VON WILLEBRAND FACTOR OR COMPLEXES THEREOF

IPC classification:
B01D 17/00, C07K 14/745
Applicant:
CSL Ltd.
Agent:
Hans-Peter Hauser, CSL Behring GmbH
Status:
EXAMINATION REQUESTED
EP14874688

FUSION PROTEINS COMPRISING FACTOR IX FOR PROPHYLACTIC TREATMENT OF HEMOPHILIA AND METHODS THEREOF

IPC classification:
A61K 38/36, A61K 38/38, A61P 7/04, C07K 14/745, C07K 14/765, C07K 19/00, C12N 9/64, C12N 15/09
Applicant:
CSL Ltd.
Agent:
Hans-Peter Hauser, CSL Behring GmbH
Status:
EXAMINATION REQUESTED
EP15775929

HALF-LIFE EXTENDED FACTOR FVIIA PROTEIN FOR PREVENTION AND TREATMENT OF BLEEDING AND DOSING REGIMENS THEREFOR

IPC classification:
A61K 38/36, A61P 7/04, C07K 14/745, C07K 19/00
Applicant:
CSL Ltd.
Agent:
Hans-Peter Hauser, CSL Behring GmbH
Status:
EXAMINATION REQUESTED
EP15741220

FACTOR VIII FORMULATION

IPC classification:
A61K 9/19, A61K 38/37
Applicant:
CSL Ltd.
Agent:
Hans-Peter Hauser, CSL Behring GmbH
Status:
EXAMINATION REQUESTED
EP15741222

IMPROVED FACTOR VIII PREPARATIONS SUITABLE FOR THERAPEUTIC USE AND PROCESSES TO OBTAIN THESE

IPC classification:
A61K 38/37, A61P 7/04
Applicant:
CSL Behring GmbH
Agent:
Hans-Peter Hauser, CSL Behring GmbH
Status:
Request for examination was made

Please Sign in to use this feature